Search research articles
Contact Us
Filters
Showing results (101-110 of 178) with videos related to
Page
of 18
Sort By:
Annals of Clinical and Translational Neurology
|
December 26, 2014
Analysis of graft survival in a trial of stem cell transplant in ALS
Tezeta Tadesse, Marla Gearing, David Senitzer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 25, 2025
pTDP-43 levels correlate with cell type-specific molecular alterations in the prefrontal cortex of <i>C9orf72</i> ALS/FTD patients
Hsiao-Lin V Wang, Jian-Feng Xiang, Chenyang Yuan, et al.
Molecular Neurodegeneration
|
October 26, 2017
Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients
Csaba Konrad, Hibiki Kawamata, Kirsten G Bredvik, et al.
Science Advances
|
October 22, 2020
Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease
Lenora Higginbotham, Lingyan Ping, Eric B Dammer, et al.
Cell Reports
|
March 20, 2026
Subtyping based on hippocampal cryptic exon burden reveals proteome-wide changes associated with TDP-43 and Alzheimer's disease pathology
Adam N Trautwig, Anantharaman Shantaraman, Mingee Chung, et al.
Muscle & Nerve
|
June 27, 2019
Class I and II histone deacetylase expression is not altered in human amyotrophic lateral sclerosis: Neuropathological and positron emission tomography molecular neuroimaging evidence
Amanda M Dios, Suma Babu, Eric J Granucci, et al.
Muscle & Nerve
|
February 28, 2025
Serious Neurologic Adverse Events in Tofersen Clinical Trials for Amyotrophic Lateral Sclerosis
Alexandra Lovett, Sowmya Chary, Suma Babu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 23, 2026
Wild-type <i>C9orf72</i> expression is a genetic modifier of C9-ALS survival
Stanislav Tsitkov, Akshay Raju, Jie Wu, et al.
Acta Neuropathologica
|
February 3, 2024
Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains
Mingee Chung, E Kathleen Carter, Austin M Veire, et al.
Annals of Clinical and Translational Neurology
|
June 10, 2020
Longitudinal biomarkers in amyotrophic lateral sclerosis
Fen Huang, Yuda Zhu, Jennifer Hsiao-Nakamoto, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 178) with videos related to
Sort By:
Page
of 18
Annals of Clinical and Translational Neurology
|
December 26, 2014
Analysis of graft survival in a trial of stem cell transplant in ALS
Tezeta Tadesse, Marla Gearing, David Senitzer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 25, 2025
pTDP-43 levels correlate with cell type-specific molecular alterations in the prefrontal cortex of <i>C9orf72</i> ALS/FTD patients
Hsiao-Lin V Wang, Jian-Feng Xiang, Chenyang Yuan, et al.
Molecular Neurodegeneration
|
October 26, 2017
Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients
Csaba Konrad, Hibiki Kawamata, Kirsten G Bredvik, et al.
Science Advances
|
October 22, 2020
Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease
Lenora Higginbotham, Lingyan Ping, Eric B Dammer, et al.
Cell Reports
|
March 20, 2026
Subtyping based on hippocampal cryptic exon burden reveals proteome-wide changes associated with TDP-43 and Alzheimer's disease pathology
Adam N Trautwig, Anantharaman Shantaraman, Mingee Chung, et al.
Muscle & Nerve
|
June 27, 2019
Class I and II histone deacetylase expression is not altered in human amyotrophic lateral sclerosis: Neuropathological and positron emission tomography molecular neuroimaging evidence
Amanda M Dios, Suma Babu, Eric J Granucci, et al.
Muscle & Nerve
|
February 28, 2025
Serious Neurologic Adverse Events in Tofersen Clinical Trials for Amyotrophic Lateral Sclerosis
Alexandra Lovett, Sowmya Chary, Suma Babu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 23, 2026
Wild-type <i>C9orf72</i> expression is a genetic modifier of C9-ALS survival
Stanislav Tsitkov, Akshay Raju, Jie Wu, et al.
Acta Neuropathologica
|
February 3, 2024
Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains
Mingee Chung, E Kathleen Carter, Austin M Veire, et al.
Annals of Clinical and Translational Neurology
|
June 10, 2020
Longitudinal biomarkers in amyotrophic lateral sclerosis
Fen Huang, Yuda Zhu, Jennifer Hsiao-Nakamoto, et al.
Page
of 18